Cargando…

Advanced Autoantibody Testing in Systemic Sclerosis

Systemic sclerosis is a systemic autoimmune rheumatic disease characterized by immune abnormalities, leading to vasculopathy and fibrosis. Autoantibody testing has become an increasingly important part of diagnosis and prognostication. Clinicians have been limited to antinuclear antibody (ANA), anti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Almaabdi, Kholoud, Ahmad, Zareen, Johnson, Sindhu R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10001109/ https://www.ncbi.nlm.nih.gov/pubmed/36899995 http://dx.doi.org/10.3390/diagnostics13050851

Ejemplares similares

Quality Measures in Systemic Sclerosis
por: Aboabat, Aos, et al.
Publicado: (2023)

Autoantibodies as Biomarker and Therapeutic Target in Systemic Sclerosis
por: Graßhoff, Hanna, et al.
Publicado: (2022)

B Cells and Autoantibodies in Multiple Sclerosis
por: Pröbstel, Anne-Katrin, et al.
Publicado: (2015)

Autoantibodies in Systemic Sclerosis: Unanswered Questions
por: Kayser, Cristiane, et al.
Publicado: (2015)

New Autoantibody Specificities in Systemic Sclerosis and Very Early Systemic Sclerosis
por: Lande, Roberto, et al.
Publicado: (2021)

Autoantibodies Which Bind to and Activate Keratinocytes in Systemic Sclerosis
por: Moezinia, Carine, et al.
Publicado: (2023)

Exercise capacity in relation to autoantibodies in systemic sclerosis patients
por: Someya, Fujiko, et al.
Publicado: (2012)

Autoantibodies are present before the clinical diagnosis of systemic sclerosis
por: Burbelo, Peter D., et al.
Publicado: (2019)

Multiparametric autoantibody profiling of patients with systemic sclerosis in Greece
por: Liaskos, Christos, et al.
Publicado: (2018)

State-of-the-art evidence in the treatment of systemic sclerosis
por: Pope, Janet E., et al.
Publicado: (2023)

Stress granules and RNA processing bodies are novel autoantibody targets in systemic sclerosis
por: Johnson, Michael E., et al.
Publicado: (2016)

Comprehensive autoantibody profiles in systemic sclerosis: Clinical cluster analysis
por: Höppner, Jakob, et al.
Publicado: (2023)

Systemic Sclerosis in Zimbabwe: Autoantibody Biomarkers, Clinical, and Laboratory Correlates
por: Sibanda, Elopy N., et al.
Publicado: (2021)

Specific Autoantibodies and Microvascular Damage Progression Assessed by Nailfold Videocapillaroscopy in Systemic Sclerosis: Are There Peculiar Associations? An Update
por: Hysa, Elvis, et al.
Publicado: (2023)

A Predictive Autoantibody Signature in Multiple Sclerosis
por: Zamecnik, Colin R., et al.
Publicado: (2023)

Emerging technologies in autoantibody testing for rheumatic diseases
por: Olsen, Nancy J., et al.
Publicado: (2017)

Safety and Effectiveness of Mycophenolate in Systemic Sclerosis. A Systematic Review
por: Omair, Mohammed A., et al.
Publicado: (2015)

Human-murine chimeric autoantibodies with high affinity and specificity for systemic sclerosis
por: Chen, Sunhui, et al.
Publicado: (2023)

Progress in understanding the diagnostic and pathogenic role of autoantibodies associated with systemic sclerosis
por: Choi, May Y., et al.
Publicado: (2016)

Increased L-Selectin on Monocytes Is Linked to the Autoantibody Profile in Systemic Sclerosis
por: Brezovec, Neža, et al.
Publicado: (2022)

Autoantibodies in the disease criteria for systemic sclerosis: The need for specification for optimal application
por: Damoiseaux, Jan, et al.
Publicado: (2022)

Review of systemic sclerosis and antineutrophil cytoplasmic antibody vasculitis overlap: Using autoantibodies for a personalised medicine approach
por: Clark, Kristina EN
Publicado: (2022)

Clinical Features of Idiopathic Interstitial Pneumonia with Systemic Sclerosis-Related Autoantibody in Comparison with Interstitial Pneumonia with Systemic Sclerosis
por: Yamakawa, Hideaki, et al.
Publicado: (2016)

Recent advances in managing systemic sclerosis
por: Aringer, Martin, et al.
Publicado: (2017)

Pathogenic Roles of Autoantibodies and Aberrant Epigenetic Regulation of Immune and Connective Tissue Cells in the Tissue Fibrosis of Patients with Systemic Sclerosis
por: Tsai, Chang-Youh, et al.
Publicado: (2020)

Plasma cytokine profiles in systemic sclerosis: associations with autoantibody subsets and clinical manifestations
por: Gourh, Pravitt, et al.
Publicado: (2009)

Predictors of progression in systemic sclerosis patients with interstitial lung disease
por: Distler, Oliver, et al.
Publicado: (2020)

Autoimmune Peripheral Neuropathies and Contribution of Antiganglioside/Sulphatide Autoantibody Testing
por: Roggenbuck, Dirk, et al.
Publicado: (2020)

Exhaled Nitric Oxide in Systemic Sclerosis Lung Disease
por: Kozij, Natalie K., et al.
Publicado: (2017)

Autoantibodies and Sjogren’s Syndrome in Multiple Sclerosis, a Reappraisal
por: Solomon, Andrew J., et al.
Publicado: (2013)

Characterising the autoantibody repertoire in systemic sclerosis following myeloablative haematopoietic stem cell transplantation
por: Ayoglu, Burcu, et al.
Publicado: (2023)

Autoantibodies and Clinical Correlations in Polish Systemic Sclerosis Patients: A Cross-Sectional Study
por: Żebryk, Paweł, et al.
Publicado: (2023)

Autoantibodies to Estrogen Receptor α in Systemic Sclerosis (SSc) as Pathogenetic Determinants and Markers of Progression
por: Giovannetti, Antonello, et al.
Publicado: (2013)

Progranulin autoantibodies in systemic sclerosis and autoimmune connective tissue disorders: A preliminary study
por: Klemm, Philipp, et al.
Publicado: (2019)

The Diagnostic and Clinical Utility of Autoantibodies in Systemic Vasculitis
por: Csernok, Elena
Publicado: (2019)

Anti-Cytokine Autoantibodies in Systemic Lupus Erythematosus
por: Howe, Hwee Siew, et al.
Publicado: (2019)

Advances in Nanotechnology-Based Biosensing of Immunoregulatory Cytokines
por: Lohcharoenkal, Warangkana, et al.
Publicado: (2021)

Recent advances in the treatment of skin involvement in systemic sclerosis
por: Asano, Yoshihide
Publicado: (2017)

Autoantibodies to angiotensin and endothelin receptors in systemic sclerosis induce cellular and systemic events associated with disease pathogenesis
por: Kill, Angela, et al.
Publicado: (2014)

Autoantibodies associated with systemic sclerosis in three autoimmune diseases imprinted by type I interferon gene dysregulation: a comparison across SLE, primary Sjögren’s syndrome and systemic sclerosis
por: Andraos, Rama, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7ljibg6cj9g8u61m1q53b4ujk1